Vancomycin in adult prescribing: is it time to move on from trough-based dosing in the UK?

F Heard1, A Sehgal2

  • 1Microbiology Department, Queens Medical Centre, Nottingham University Hospitals Trust, Derby Road, Nottingham NG7 2UH, UK.

Insights

Vancomycin dosing should shift from trough-based to 24-hour AUC/MIC monitoring for improved efficacy and reduced nephrotoxicity. This change is crucial for safe vancomycin use, especially for MRSA infections.

Area of Science:

  • Pharmacology
  • Infectious Diseases
  • Clinical Pharmacy

Background:

  • Vancomycin is vital for treating Staphylococcus aureus and MRSA infections.
  • Therapeutic drug monitoring (TDM) is essential for vancomycin efficacy and safety.
  • Trough-based dosing, previously standard, faces scrutiny regarding reliability and patient risk.

Purpose of the Study:

  • To advocate for the adoption of 24-hour AUC/MIC-based vancomycin dosing.
  • To highlight the risks associated with continued reliance on trough-based dosing, particularly nephrotoxicity.
  • To align UK vancomycin dosing practices with international guidelines.

Main Methods:

  • Review of current vancomycin dosing guidelines and evidence.
  • Analysis of the risks and benefits of trough-based versus AUC/MIC-based dosing.
  • Comparison of UK practices with international recommendations (e.g., IDSA 2020 guidelines).

Main Results:

  • The 2020 IDSA guidelines recommend 24-hour AUC/MIC dosing over trough-based methods.
  • Evidence indicates trough-based dosing increases the risk of vancomycin-induced nephrotoxicity.
  • The UK has not yet fully implemented AUC/MIC-based dosing, lagging behind evidence-based recommendations.

Conclusions:

  • Transitioning to AUC/MIC-based vancomycin dosing is necessary for patient safety.
  • Implementing AUC/MIC dosing will optimize vancomycin efficacy and minimize toxicity.
  • Adopting AUC/MIC dosing aligns clinical practice with current scientific evidence and guidelines.

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
47
Determination of Multiple Dosing Parameters: Steady-State, Minimum and Maximum Concentrations01:15

Determination of Multiple Dosing Parameters: Steady-State, Minimum and Maximum Concentrations

Gentamicin, an aminoglycoside antibiotic, is commonly administered via intermittent intravenous infusion to treat severe infections. An intermittent one-hour infusion of gentamicin, administered at eight-hour intervals, allows for precise control of plasma drug concentrations, minimizing toxicity while ensuring therapeutic efficacy. Pharmacokinetic principles govern the dynamics of plasma concentrations and can be mathematically described using specific equations.The plasma drug concentration...
39
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
57
Drug Dosing: Geriatric Patients01:15

Drug Dosing: Geriatric Patients

Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
49
Drug Dosing in Renal Diseases: Dose Adjustments Based on Drug Clearance and Elimination Rate Constant01:25

Drug Dosing in Renal Diseases: Dose Adjustments Based on Drug Clearance and Elimination Rate Constant

In patients with renal disease, dosage adjustments are necessary to maintain therapeutic plasma drug concentrations and prevent toxicity or subtherapeutic exposure. Renal impairment alters drug pharmacokinetics, especially in conditions like uremia, where changes such as prolonged elimination half-life and altered apparent volume of distribution can significantly affect drug disposition. These changes require careful modification of the dosing regimen to achieve the desired clinical...
33
Dosage Interval and Administration Route: Determination Methods01:19

Dosage Interval and Administration Route: Determination Methods

A medication’s effectiveness largely depends on its appropriate dosage and the route of administration. Dosage ensures that a sufficient drug concentration is maintained in the bloodstream to elicit the desired therapeutic effect without causing toxicity. The route of administration affects the drug's bioavailability, rate of absorption, and onset of action, which are crucial for achieving optimal therapeutic outcomes. Drug dosage calculations are critical to tailoring therapy to...
52